Think Twice Before Divesting In Crispr Amid Cancer Concerns [Seeking Alpha]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Seeking Alpha
Summary Two publications released Monday morning suggest CRISPR-Cas9 editing may lead to systematic propagation of cancer-prone cells. Despite reactive divestment in CRISPR-related stocks, these technical concerns appear irrelevant to leading therapeutic candidates. Conservative investors should stay long, and aggressive investors may entertain capitalizing on the dip and increasing holdings. By Chris Lew , Senior Analyst, DeciBio Consulting Two papers published by Novartis and Karolinska Institute that warn of potential cancer risks associated with CRISPR-Cas9 editing sent share prices of CRISPR Therapeutics ( CRSP, -12.17%), Editas Medicine ( EDIT , -8.13%), and Intellia Therapeutics ( NTLA , -8.63%) tumbling Monday morning. The studies found that editing efficiency of CRISPR-Cas9 may rely on dysfunction of a pathway critical for cancer prevention. In other words, successful CRISPR-Cas9 editing may in part rely on a cell being tumor-prone. Tumor prote
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Bullish Trendline Has Never Failed Crispr Therapeutics Stock [Yahoo! Finance]Yahoo! Finance
- Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- bluebird (BLUE) Underperforms Industry YTD Amid Challenges [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 2/21/24 - Beat
CRSP
Sec Filings
- 4/17/24 - Form 4
- 4/15/24 - Form 144
- 4/10/24 - Form SC
- CRSP's page on the SEC website